VENICE, Fla., Dec. 2, 2010 (GLOBE NEWSWIRE) -- SinoFresh®HealthCare, Inc., (Pink Sheets:SFSH) announces that is has acquired 100% of SinoFresh Healthcare Products, Inc., which was previously a privately held marketing and manufacturing company operating under exclusive contract with SinoFresh HealthCare, Inc.
The company's premier product, SinoFresh Homeopathic Nasal & Sinus Care is a "refreshing alternative to ineffective or habit-forming over the counter medications for sinus sufferers," states SinoFresh HealthCare CEO, David R. Olund. "Market demand is ever-increasing with an estimated 37 million sinus sufferers in the US alone, and even medical professionals are becoming more open to recommending non-prescriptive solutions. We are confident that the acquisition of SinoFresh Healthcare Products, Inc. will only further our success in the markets with what we feel are uniquely effective products."
The acquisition was performed to consolidate the companies into a unified operating business model. "We are now positioned to deploy a time-tested strategy to streamline distribution of our products through global wholesale retail and online outlets. "We expect to be adding additional products to our line in the near future with anticipated success for our existing focus," adds Olund.
SinoFresh HealthCare, Inc. is a publicly traded company (Pink Sheets:SFSH) based in Venice, Florida, that manufactures and distributes nasal, oral and topical antiseptic germ-killing products. SinoFresh products are marketed and distributed globally through a network of strategic wholesale and retail partners. SinoFresh Healthcare, Inc.'s premier product, SinoFresh Antiseptic Homeopathic Nasal spray, has in laboratory tests shown effective antiseptic capability against a variety of pathogens such as MRSA, E-Coli, H1N1 and a broad range of other viruses, molds, fungi and bacteria.
For more information please contact our Investor Relations department at 941.375.8174
This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Our forward-looking statements express our current expectations or forecasts of possible future results or events, including projections of future performance, statements of management's plans and objectives, future contracts, and forecasts of trends and other matters. Forward-looking statements speak only as of the date of this filing, and we undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur. You can identify these statements by the fact that they do not relate strictly to historic or current facts and often use words such as "anticipate", "estimate", "expect", "believe", "will likely result", "outlook", "project" and other words and expressions of similar meaning. No assurance can be given that the results in any forward-looking statements will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.